Emanuel Kanal

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center Presbyterian, 200 Lothrop St, Room D 132, Pittsburgh, PA 15213 2582, USA
    Radiology 246:11-4. 2008
  2. doi request reprint ACR guidance document on MR safe practices: 2013
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    J Magn Reson Imaging 37:501-30. 2013
  3. doi request reprint Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213 2582, USA
    Magn Reson Imaging Clin N Am 20:625-31. 2012
  4. ncbi request reprint ACR Blue Ribbon Panel response to the AJR commentary by Shellock and Crues on the ACR White Paper on MR Safety
    Emanuel Kanal
    Department of Radiology, Magnetic Resonance Services, University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 180:31-5. 2003
  5. ncbi request reprint American College of Radiology White Paper on MR Safety: 2004 update and revisions
    Emanuel Kanal
    Department of Radiology, Magnetic Resonance Services, University of Pittsburgh, 200 Lothrop St, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 182:1111-4. 2004
  6. ncbi request reprint ACR guidance document for safe MR practices: 2007
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    AJR Am J Roentgenol 188:1447-74. 2007
  7. ncbi request reprint American College of Radiology White Paper on MR Safety
    Emanuel Kanal
    Department of Radiology, Magnetic Resonance Services, University of Pittsburgh Medical Center 200 Lothrop St, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 178:1335-47. 2002
  8. doi request reprint Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine
    Andrew G Bleicher
    Department of Radiology, Division of Neuroradiology, University of Pittsburgh Medical Center, 200 Lothrop St, Rm D 132, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 191:W307-11. 2008
  9. doi request reprint Intracranial arterialized venous angioma: case report with new insights from functional brain MRI
    Nestor D Tomycz
    Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Diagn Interv Radiol 16:13-5. 2010
  10. ncbi request reprint Response to "Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?"
    Dale R Broome
    AJR Am J Roentgenol 189:W234-5. 2007

Detail Information

Publications11

  1. ncbi request reprint Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center Presbyterian, 200 Lothrop St, Room D 132, Pittsburgh, PA 15213 2582, USA
    Radiology 246:11-4. 2008
  2. doi request reprint ACR guidance document on MR safe practices: 2013
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    J Magn Reson Imaging 37:501-30. 2013
    ..As the MR industry changes the document is reviewed, modified and updated. The most recent version will reflect these changes...
  3. doi request reprint Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213 2582, USA
    Magn Reson Imaging Clin N Am 20:625-31. 2012
    ....
  4. ncbi request reprint ACR Blue Ribbon Panel response to the AJR commentary by Shellock and Crues on the ACR White Paper on MR Safety
    Emanuel Kanal
    Department of Radiology, Magnetic Resonance Services, University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 180:31-5. 2003
  5. ncbi request reprint American College of Radiology White Paper on MR Safety: 2004 update and revisions
    Emanuel Kanal
    Department of Radiology, Magnetic Resonance Services, University of Pittsburgh, 200 Lothrop St, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 182:1111-4. 2004
  6. ncbi request reprint ACR guidance document for safe MR practices: 2007
    Emanuel Kanal
    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    AJR Am J Roentgenol 188:1447-74. 2007
  7. ncbi request reprint American College of Radiology White Paper on MR Safety
    Emanuel Kanal
    Department of Radiology, Magnetic Resonance Services, University of Pittsburgh Medical Center 200 Lothrop St, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 178:1335-47. 2002
  8. doi request reprint Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine
    Andrew G Bleicher
    Department of Radiology, Division of Neuroradiology, University of Pittsburgh Medical Center, 200 Lothrop St, Rm D 132, Pittsburgh, PA 15213 2582, USA
    AJR Am J Roentgenol 191:W307-11. 2008
    ..Data were collected to assess the relative risk of using gadobenate dimeglumine compared with published data for other approved agents and for this agent in preclinical testing...
  9. doi request reprint Intracranial arterialized venous angioma: case report with new insights from functional brain MRI
    Nestor D Tomycz
    Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Diagn Interv Radiol 16:13-5. 2010
    ..The arterialized venous angioma represents an uncommon, "mixed" intracranial vascular lesion whose natural history remains unknown...
  10. ncbi request reprint Response to "Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?"
    Dale R Broome
    AJR Am J Roentgenol 189:W234-5. 2007
  11. ncbi request reprint Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
    Phillip H Kuo
    Radiology 242:647-9. 2007